microbiology, Vol 141, 1909-1920, Copyright © 1995 by Society for General Microbiology

ARTICLES

Multidrug resistance in Klebsiella pneumoniae: a novel gene, ramA, confers a multidrug resistance phenotype in Escherichia coli

AM George, RM Hall and HW Stokes
Department of Biochemistry and Physiology, University of Technology, Sydney, NSW, Australia.

Spontaneous multidrug-resistant (Mdr) mutants of Klebsiella pneumoniae strain ECL8 arose at a frequency of 2.2 x 10(-8) and showed increased resistance to a range of unrelated antibiotics, including chloramphenicol, tetracycline, nalidixic acid, ampicillin, norfloxacin, trimethoprim and puromycin. A chromosomal fragment from one such mutant was cloned, and found to confer an Mdr phenotype on Escherichia coli K12 cells that was essentially identical to that of the K. pneumoniae mutant. Almost complete loss of the OmpF porin in the E. coli transformant, and of the corresponding porin in the K. pneumoniae mutant, was observed. The presence of the Mdr mutation in K. pneumoniae or the cloned K. pneumoniae ramA (resistance antibiotic multiple) locus in E. coli also resulted in active efflux of tetracycline, and increased active efflux of chloramphenicol. After transformation of a ramA plasmid into E. coli, expression of chloramphenicol resistance occurred later than expression of resistance to tetracycline, puromycin, trimethoprim and nalidixic acid. The ramA gene was localized and sequenced. It encodes a putative positive transcriptional activator that is weakly related to the E. coli MarA and SoxS proteins. A ramA gene was also found to be present in an Enterobacter cloacae fragment that has previously been shown to confer an Mdr phenotype, and it appears that ramA, rather than the romA gene identified in that study, is responsible for multidrug resistance. The ramA gene from the wild- type K. pneumoniae was identical to that of the mutant strain and also conferred an Mdr phenotype on E. coli, indicating that the mutation responsible for Mdr in K. pneumoniae had not been cloned.

This article has been cited by other articles:

				O. Kallman, A. Motakefi, B. Wretlind, M. Kalin, B. Olsson-Liljequist, and C. G. Giske Cefuroxime non-susceptibility in multidrug-resistant Klebsiella pneumoniae overexpressing ramA and acrA and expressing ompK35 at reduced levels J. Antimicrob. Chemother., July 21, 2008; (2008) dkn296v1. [Abstract] [Full Text] [PDF]

				S. Chen, S. Cui, P. F. McDermott, S. Zhao, D. G. White, I. Paulsen, and J. Meng Contribution of Target Gene Mutations and Efflux to Decreased Susceptibility of Salmonella enterica Serovar Typhimurium to Fluoroquinolones and Other Antimicrobials Antimicrob. Agents Chemother., February 1, 2007; 51(2): 535 - 542. [Abstract] [Full Text] [PDF]

				F. M. Kaczmarek, F. Dib-Hajj, W. Shang, and T. D. Gootz High-Level Carbapenem Resistance in a Klebsiella pneumoniae Clinical Isolate Is Due to the Combination of blaACT-1 {beta}-Lactamase Production, Porin OmpK35/36 Insertional Inactivation, and Down-Regulation of the Phosphate Transport Porin PhoE. Antimicrob. Agents Chemother., October 1, 2006; 50(10): 3396 - 3406. [Abstract] [Full Text] [PDF]

				L. J. V. Piddock Clinically Relevant Chromosomally Encoded Multidrug Resistance Efflux Pumps in Bacteria Clin. Microbiol. Rev., April 1, 2006; 19(2): 382 - 402. [Abstract] [Full Text] [PDF]

				A. Ruzin, M. A. Visalli, D. Keeney, and P. A. Bradford Influence of Transcriptional Activator RamA on Expression of Multidrug Efflux Pump AcrAB and Tigecycline Susceptibility in Klebsiella pneumoniae Antimicrob. Agents Chemother., March 1, 2005; 49(3): 1017 - 1022. [Abstract] [Full Text] [PDF]

				M. M Tavio, J. Vila, M. Perilli, L. T Casanas, L. Macia, G. Amicosante, and M. T Jimenez de Anta Enhanced active efflux, repression of porin synthesis and development of Mar phenotype by diazepam in two enterobacteria strains J. Med. Microbiol., November 1, 2004; 53(11): 1119 - 1122. [Abstract] [Full Text] [PDF]

				R. Chollet, J. Chevalier, C. Bollet, J.-M. Pages, and A. Davin-Regli RamA Is an Alternate Activator of the Multidrug Resistance Cascade in Enterobacter aerogenes Antimicrob. Agents Chemother., July 1, 2004; 48(7): 2518 - 2523. [Abstract] [Full Text] [PDF]

				T. van der Straaten, R. Janssen, D. J. Mevius, and J. T. van Dissel Salmonella Gene rma (ramA) and Multiple-Drug-Resistant Salmonella enterica Serovar Typhimurium Antimicrob. Agents Chemother., June 1, 2004; 48(6): 2292 - 2294. [Abstract] [Full Text] [PDF]

				T. van der Straaten, L. Zulianello, A. van Diepen, D. L. Granger, R. Janssen, and J. T. van Dissel Salmonella enterica Serovar Typhimurium RamA, Intracellular Oxidative Stress Response, and Bacterial Virulence Infect. Immun., February 1, 2004; 72(2): 996 - 1003. [Abstract] [Full Text] [PDF]

				T. Schneiders, S. G. B. Amyes, and S. B. Levy Role of AcrR and RamA in Fluoroquinolone Resistance in Clinical Klebsiella pneumoniae Isolates from Singapore Antimicrob. Agents Chemother., September 1, 2003; 47(9): 2831 - 2837. [Abstract] [Full Text] [PDF]

				D. H. Kwon, M. P. Dore, J. J. Kim, M. Kato, M. Lee, J. Y. Wu, and D. Y. Graham High-Level {beta}-Lactam Resistance Associated with Acquired Multidrug Resistance in Helicobacter pylori Antimicrob. Agents Chemother., July 1, 2003; 47(7): 2169 - 2178. [Abstract] [Full Text] [PDF]

				S. Gayet, R. Chollet, G. Molle, J.-M. Pages, and J. Chevalier Modification of Outer Membrane Protein Profile and Evidence Suggesting an Active Drug Pump in Enterobacter aerogenes Clinical Strains Antimicrob. Agents Chemother., May 1, 2003; 47(5): 1555 - 1559. [Abstract] [Full Text] [PDF]

				L. Martinez-Martinez, A. Pascual, M. d. C. Conejo, I. Garcia, P. Joyanes, A. Domenech-Sanchez, and V. J. Benedi Energy-Dependent Accumulation of Norfloxacin and Porin Expression in Clinical Isolates of Klebsiella pneumoniae and Relationship to Extended-Spectrum {beta}-Lactamase Production Antimicrob. Agents Chemother., December 1, 2002; 46(12): 3926 - 3932. [Abstract] [Full Text] [PDF]

				N. Valkova, F. Lepine, C. Bollet, M. Dupont, and R. Villemur prbA, a Gene Coding for an Esterase Hydrolyzing Parabens in Enterobacter cloacae and Enterobacter gergoviae Strains J. Bacteriol., September 15, 2002; 184(18): 5011 - 5017. [Abstract] [Full Text] [PDF]

				H.-J. Linde, F. Notka, C. Irtenkauf, J. Decker, J. Wild, H.-H. Niller, P. Heisig, and N. Lehn Increase in MICs of ciprofloxacin in vivo in two closely related clinical isolates of Enterobacter cloacae J. Antimicrob. Chemother., April 1, 2002; 49(4): 625 - 630. [Abstract] [Full Text] [PDF]

				Mahmoud. A. Yassien, H. E. Ewis, C.-D. Lu, and A. T. Abdelal Molecular Cloning and Characterization of the Salmonella enterica Serovar Paratyphi B rma Gene, Which Confers Multiple Drug Resistance in Escherichia coli Antimicrob. Agents Chemother., February 1, 2002; 46(2): 360 - 366. [Abstract] [Full Text] [PDF]

				F. Notka, H.-J. Linde, A. Dankesreiter, H.-H. Niller, and N. Lehn A C-terminal 18 amino acid deletion in MarR in a clinical isolate of Escherichia coli reduces MarR binding properties and increases the MIC of ciprofloxacin J. Antimicrob. Chemother., January 1, 2002; 49(1): 41 - 47. [Abstract] [Full Text] [PDF]

				I. Chopra and M. Roberts Tetracycline Antibiotics: Mode of Action, Applications, Molecular Biology, and Epidemiology of Bacterial Resistance Microbiol. Mol. Biol. Rev., June 1, 2001; 65(2): 232 - 260. [Abstract] [Full Text] [PDF]

				E. De Rossi, M. C. J. Blokpoel, R. Cantoni, M. Branzoni, G. Riccardi, D. B. Young, K. A. L. De Smet, and O. Ciferri Molecular Cloning and Functional Analysis of a Novel Tetracycline Resistance Determinant, tet(V), from Mycobacterium smegmatis Antimicrob. Agents Chemother., August 1, 1998; 42(8): 1931 - 1937. [Abstract] [Full Text]

				L. Martínez-Martínez, I. García, S. Ballesta, V. J. Benedí, S. Hernández-Allés, and A. Pascual Energy-Dependent Accumulation of Fluoroquinolones in Quinolone-Resistant Klebsiella pneumoniae Strains Antimicrob. Agents Chemother., July 1, 1998; 42(7): 1850 - 1852. [Abstract] [Full Text]